Summary
Urinary albumin excretion has been assessed in 585 newly-presenting Type 2 (non-insulin-dependent) diabetic patients (aged 53 (8) years, 67% male) at diagnosis with fasting plasma glucose 10.3 (3.2) mmol/l and over 3 years of dietary treatment. Urinary albumin at diagnosis, geometric mean (1 SD interval) corrected for dilution by regression on urine creatinine concentration of 10 mmol/l, was 17(5–58) mg/l compared with 8 (3–18) mg/l in an agematched non-diabetic reference population. Values greater than 50 mg/l were found in 17% of diabetic patients compared with 4% in the reference group. After diet therapy for 3 months, fasting plasma glucose decreased to 6.9 mmol/l and urinary albumin to 12 (4–31) mg/l (p<0.0001). This suggests that increased urinary albumin excretion at diagnosis is in part functional, possibly secondary to glomerular hyperfiltration caused by hyperglycaemia and raised blood pressure. Over the next 3 years, mean fasting plasma glucose was 7.2 mmol/l, albumin excretion changed little, without significant increase either in patients with raised or normal albumin at diagnosis. Both at diagnosis and over 3 years, urinary albumin excretion was independently associated with fasting plasma glucose and triglyceride levels and with systolic blood pressure, but the combination of these factors only explained 10% of the total variance. This suggests the presence of additional pathological processes in patients with increased urinary albumin. Urinary albumin was not associated with other variables included in syndrome X, such as HDL cholesterol, fasting plasma insulin, obesity or central adiposity. The lack of change in urinary albumin over 3 years, even in subjects with raised excretion and in the highest group for glycaemia, indicates that the pathological processes are only slowly progressive in these asymptomatic patients. Increased cardiovascular mortality associated with raised urinary albumin excretion may in part be secondary to the associated hypertension and elevated triglyceride levels.
References
Jarrett RJ, Viberti GC, Argyropolous A, Hill RD, Mahmus U, Murrells TJ (1984) Microalbuminuria predicts mortality in noninsulin-dependent diabetics. Diabetic Med 1:17–19
Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H (1990) A prospective study of mortality among middle-aged diabetic patients: the London cohort of the WHO multinational Study of Vascular Disease in Diabetics II: associated risk factors. Diabetologia 33:542–548
Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360
Schmitz A, Vaeth M (1987) Microalbuminuria: a major risk factor for non-insulin-dependent diabetes. A 10 year follow-up study of 503 patients. Diabetic Med 5:126–134
Mattock MB, Keen H, Viberti GC et al. (1988) Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:82–87
Deckert T, Feldt-Rasmussen B, Borch-Johnson K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226
Wiseman MJ, Viberti GC, Mackintosh D, Jarrett RJ, Keen H (1984) Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–405
Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406–410
Gatling W, Mullee MA, Knight C, Hill RD (1988) Microalbu minuria in diabetes: relationship between urinary albumin excretion and diabetes-related variables Diabetic Med 5:348–351
UK Prospective Diabetes Study 6 (1990) Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 13: 1–11
Manley SE, Cull CA, Burton ME et al. (1993) UK Prospective Diabetes Study (UKPDS) IX: Relationships of urinary a albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 36:835–842
Allawi J, Jarrett RJ (1989) Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus. Diabetic Med 7:115–118
Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I, Pyörälä K (1990) Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:237–243
Mattock MB, Morris NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson PG (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:736–741
Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHR, Donker AJM, Den Ottolander GJH (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319–323
Seghieri G, Alviggi L, Caselli P et al. (1990) Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria Diabetic Med 7:810–814
Kapelrud H, Bangstad H-J, Dahl-Jørgensen K, Berg K, Hanssen KF (1991) Serum Lp(a) liporrotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ 303: 675–678
Jensen T, Stender S, Deckert T (1988) Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulindependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31:142–145
Winocour PH, Bhatnagar D, Ishola M, Arrol S, Durrington PN (1991) Lipoprotein(a) and microvascular disease in type 1 (insulin-dependent) diabetes. Diabetic Med 8:922–927
Dullaart RP, Dikkeschei LD, Doorenbos H (1989) Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 32: 685–689
Watts GF, Naumova R, Slavin BM et al. (1989) Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria. Diabetic Med 6:25–30
Patrick AW, Leslie PJ, Clarke BF, Frier BM (1990) The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 8:902–908
Martin P, Hampton KK, Walton C, Tindall H, Daview JA (1989) Microproteinuria in type 2 diabetes mellitus from diagnosis. Diabetic Med 7:315–318
Vasquez B, Flock EV, Savage PJ et al. (1984) Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 26:127–133
Schmitz A, Hvid Hansen H, Christensen T (1989) Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 32: 434–439.
UK Prospective Diabetes Study Group (1991) UK Prospective Diabetes Study Group (UKPDS). VIII. Study design, progress and performance. Diabetologia 34:877–890.
Wright BM, Dore CF (1970) A random zero sphygmomanometer. Lancet I:33–35.
Westgard JO, Barry PL, Hunt MR (1981) A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 27:493–501.
Woo J, Floyd M, Cannon DC, Kahan B (1978) Radioimmunoassay for urinary albumin. Clin Chem 24:1464–1467
Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN (1987) Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J. Clin Path 40:465–468.
Jaffé M (1886) Ueber den Neiderschlag, welchen Pikrinsaure in normalen Harn erzeugt und ueber eine neue Reaktion des Kreatinins. Z Physiol Chem 10:391–400
Di Giorgio J (1974) Automated determination of serum and urine creatinine. In: Henry RJ, Cannon DC, Winkelman JW (eds) Clinical chemistry. Principles and techniques. Harper and Row, Hagerstown, pp 552–553
Wahlefeld AW (1974) Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer M (ed) Methods of enzymatic analysis. 2nd edn vol 4. Verlag Chemie Weinheim and Academic Press. Inc. New York London, pp 1831–1835
Huang TC, Chen CP, Wefler V, Raftery A (1961) A stable reagent for the Liebermann-Burchard reaction. Application to rapid serum cholesterol determination. Analytical Chem 33:1405–1407
Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19:838–839.
Burstein M, Scholnick HR, Morfin R (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Research 11:583–594
Albano JM, Ekins RP, Martiz G, Turner RC (1972) A sensitive precise radio-immunoassay of human insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70:487–509
Moore JC, Bown E, Outlaw MC, Jelfs R, Holman RR, Turner RC (1986) Glycosylated haemoglobin: comparison of five different methods including measurement on capillary blood samples. Ann Clin Biochem 23:85–91
Eeley E, Stratton IM, James R, Holman RR (1992) Dietary evaluation in type 2 diabetic subjects randomly allocated to insulin sulphonylurea or diet therapy. Diabetologia 35 [Suppl 1]: A165 (Abstract)
SAS Institute Inc (1990) SAS user guide, Version 6. SAS Institute Inc, Cary
Thompson SG, Barlow RD, Wald NJ, Vunakis HV (1990) How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta 187:289–295
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607
Mogensen CE, Andersen MJF (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706–713
Kasiske BL, O'Donnell MP, Cleary MP, Keane WF (1988) Treatment of hyperlipidaemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667–672
Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144–148
Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297–300
Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet II:530–533
Pettitt DJ, Knowler WC, Lisse JR, Bennett PH (1980) Development of retinopathy and proteinuria in relation to plasma glucose concentrations in Pima Indians. Lancet II:1050–1052
Author information
Authors and Affiliations
Consortia
Additional information
This manuscript was prepared by C. Cull, S. Manley, V. Frighi, R. Holman, R. Turner for the UKPDS Group
Rights and permissions
About this article
Cite this article
UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). Diabetologia 36, 1021–1029 (1993). https://doi.org/10.1007/BF02374494
Issue Date:
DOI: https://doi.org/10.1007/BF02374494